Regulation of Fibroblast Growth Factor-inducible 14 (Fn14) Expression Levels Via Ligand-independent Lysosomal Degradation
Overview
Affiliations
Fibroblast growth factor-inducible 14 (Fn14) is a highly inducible cytokine receptor that engages multiple intracellular signaling pathways, including nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK). Fn14 expression is regulated by several cytokines and growth factors, and Fn14 is transiently up-regulated after injury. In contrast, in states of chronic inflammatory disease and in some solid tumors, Fn14 is persistently up-regulated. However, the post-translational regulation of Fn14 expression has not been directly investigated. Thus, we examined Fn14 proteostasis in the presence and absence of the Fn14 ligand TNF-like weak inducer of apoptosis (TWEAK). Similar to other TNF receptor superfamily members, we found that TWEAK induces Fn14 internalization and degradation. Surprisingly, we also observed rapid, TWEAK-independent, constitutive Fn14 internalization and turnover. Fn14 levels are maintained in cell culture by ongoing synthesis and trafficking of the receptor, leading to subsequent down-regulation by lysosomal degradation. Unexpectedly, the extracellular domain of Fn14 is necessary and sufficient for constitutive turnover. Based on these findings, we propose a model in which constitutive down-regulation of Fn14 facilitates dynamic regulation of Fn14 protein levels and prevents spontaneous or inappropriate receptor signaling.
Carney C, Kapur A, Anastasiadis P, Ritzel R, Chen C, Woodworth G Mol Pharm. 2022; 20(1):314-330.
PMID: 36374573 PMC: 11056964. DOI: 10.1021/acs.molpharmaceut.2c00663.
Chen Y, Liu P, Tang K, Liu H, Liao T Microbiol Spectr. 2022; 10(6):e0317222.
PMID: 36321903 PMC: 9769850. DOI: 10.1128/spectrum.03172-22.
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.
Guner G, Assfalg M, Zhao K, Dreyer T, Lahiri S, Lo Y EMBO Mol Med. 2022; 14(10):e16084.
PMID: 36069059 PMC: 9549706. DOI: 10.15252/emmm.202216084.
Ortega M, Villiger R, Harrison-Chau M, Lieu S, Tamashiro K, Lee A Dis Model Mech. 2022; 15(10).
PMID: 36004645 PMC: 9586569. DOI: 10.1242/dmm.049785.
NF-κB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders?.
Roberti A, Chaffey L, Greaves D Biology (Basel). 2022; 11(3).
PMID: 35336746 PMC: 8945680. DOI: 10.3390/biology11030372.